APOTEX INC FDA Approval ANDA 091303

ANDA 091303

APOTEX INC

FDA Drug Application

Application #091303

Application Sponsors

ANDA 091303APOTEX INC

Marketing Status

Prescription001

Application Products

001TABLET;ORAL2.5MG0LETROZOLELETROZOLE

FDA Submissions

ORIG1AP2012-04-19
LABELING; LabelingSUPPL2AP2019-05-19STANDARD
LABELING; LabelingSUPPL3AP2019-05-19STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null7
SUPPL3Null7

TE Codes

001PrescriptionAB

CDER Filings

APOTEX INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91303
            [companyName] => APOTEX INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"LETROZOLE","activeIngredients":"LETROZOLE","strength":"2.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"LETROZOLE","submission":"LETROZOLE","actionType":"2.5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.